RFKjr: MRNA vaccines pose more risks then benefits

RFKjr.: "HHS has determined that mRNA technology carries more risks than benefits" for humans with respect to respiratory viruses.

RFKJr. cancels $ 500 million in mRNA research, HHS prioritizes "safer" alternatives.

RFKjr.: "The data show that these [mRNA] vaccines do not provide effective protection against upper respiratory tract infections, such as COVID and influenza."